Nisa Investment Advisors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-191
Closed -$1.28K 3082
2025
Q3
$1.28K Buy
191
+146
+324% +$953 ﹤0.01% 2700
2025
Q2
$265 Sell
45
-229
-84% -$1.49K ﹤0.01% 2948
2025
Q1
$2.3K Buy
274
+44
+19% +$395 ﹤0.01% 2433
2024
Q4
$1.71K Buy
230
+215
+1,433% +$1.44K ﹤0.01% 2539
2024
Q3
$87 Sell
15
-9,257
-100% -$59.5K ﹤0.01% 2915
2024
Q2
$61.7K Buy
9,272
+9,245
+34,241% +$74.7K ﹤0.01% 1608
2024
Q1
$352 Buy
+27
New +$360 ﹤0.01% 2562
2023
Q4
Sell
-10
Closed -$131 2745
2023
Q3
$131 Sell
10
-16
-62% -$293 ﹤0.01% 2709
2023
Q2
$665 Buy
+26
New +$671 ﹤0.01% 2501
2022
Q4
Sell
-24
Closed -$1K 2726
2022
Q3
$1K Buy
+24
New +$464 ﹤0.01% 2518

Other funds holding TMCI

Nisa Investment Advisors's TMCI Position: Q4 2025 in Review

Nisa Investment Advisors sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 191 shares — an estimated $1.28K sold.

Nisa Investment Advisors first reported a position in TMCI in Q3 2022 and held it in 10 quarters. The position peaked at $61.7K in Q2 2024. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Nisa Investment Advisors reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 191 Treace Medical Concepts shares in Q4 2025, an estimated $1.28K.
  • Nisa Investment Advisors first reported a position in Treace Medical Concepts in Q3 2022 and held it in 10 quarters.
  • Nisa Investment Advisors's Treace Medical Concepts position peaked at $61.7K in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.